Скачать с ютуб Echosens Webinar on NAFLD/NASH в хорошем качестве

Echosens Webinar on NAFLD/NASH

➡️ CHECK OUT OUR MOST RECENT WEBINARS IN REPLAY ➡️ https://bit.ly/echosenswbnyb Feasibility & clinical utility of FibroScan (Liver stiffness, CAP) for management of NAFLD/NASH patients Speakers: Dr Jason CHANG & Dr George GOH Contact: [email protected] Legal Mentions: ECHOSENS_WEBINAR_REPLAY2017- Revision date 12/08/2016 - FibroScan® is a medical device manufactured by Echosens. FibroScan is a CE marked Medical Device within the scope of the Medical Devices Directive. FibroScan® is indicated for the non invasive measurement of liver stiffness (E) and controlled attenuation parameter (CAP) in humans. It is expressly recommended to carefully read the guidance within the users' guide and the labeling of the device. FibroScan® examinations must only be performed at the request of qualified physician and by operators certified by the manufacturer or its accredited local representative. The values obtained with FibroScan® must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patient. DISCLAIMER : Our products are subject to regulatory requirements that vary from country to country and therefore may not be available for sale or distribution in all markets. This video is not intended for US audience : http://www.echosens.us/ .